Catalyst Wire Dossier Catalyst Wire Dossier

Aclidinium/Formoterol Fixed Dose Combination

aclidinium/formoterol fixed-dose combination · AstraZeneca
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Aclidinium/Formoterol Fixed Dose Combination, covering 2016-08-08 to 2016-11-23. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic, Safety and Tolerability Study of Aclidinium/Formoterol Fixed Dose Combination and Formoterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

See pricing